News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ivy Riano: IASLC Lung Cancer Considered Podcast
Photo from Ivy Riano/LinkedIn
May 18, 2024, 10:43

Ivy Riano: IASLC Lung Cancer Considered Podcast

Ivy Riano, Hematology and Oncology Research Chief Fellow at Dartmouth-Hitchcock, shared on LinkedIn:

“In case you missed it, here is our IASLC Lung Cancer Considered Podcast episode where we discussed about barriers to biomarker testing in lung cancer with Drs. Florez and Gorria. En Español!”

Source: Ivy Riano/LinkedIn

cancer Dartmouth-Hitchcock IASLC Ivy Riano Lung cancer Lung Cancer Considered Podcast Narjust Florez OncoDaily Oncology Teresa Gorria
Blog
Aug 12, 2024, 02:37
Biagio Ricciuti: Vulnerabilities to GPX4 and HDAC inhibitors in BRAF V600E lung adenocarcinoma
Blog
Aug 12, 2024, 02:33
Carmen Uscatu: When the meaning of the future lies in our past
Blog
Aug 12, 2024, 02:23
Rafael Fonseca: Defining CRS and ICANs risks
Blog
Aug 12, 2024, 02:15
Expert Working Group of EC-CvC will review cervical screening during a meeting at IARC
Blog
Aug 12, 2024, 02:14
Yale Cancer Center - Lymphir offers hope for Skin Disease in cutaneous T-cell lymphoma
Blog
Aug 12, 2024, 02:01
Maciej M Mrugala: Wonderful program for Early Career Professionals and Young Investigators
Blog
Aug 12, 2024, 01:52
Mainak Bardhan: Wonderful and busy start of the PhD program at University of Miami’s Miller School of Medicine
Blog
Aug 12, 2024, 01:50
From survivor to advocate: Kyle DeLeon's fight for equity in cancer care
Blog
Aug 12, 2024, 01:44
Jill Barnholtz-Sloan: Evolutionary Biomarkers to predict prostate cancer re-occurrence
Blog
Aug 12, 2024, 01:35
Joshua Zeidner: Highly impactful data for R/R AML and menin inhibitors
Blog
Aug 12, 2024, 01:34
Sachin H. Jain: The trend of health systems exiting the Medicare Advantage program
Blog
Aug 12, 2024, 01:27
Michael Ong received $2.4M for metastatic prostate cancer - CCTG